首页> 美国卫生研究院文献>other >The Immunosuppressant Protosappanin A Diminished Recipient T Cell Migration into Allograft via Inhibition of IP-10 in Rat Heart Transplant
【2h】

The Immunosuppressant Protosappanin A Diminished Recipient T Cell Migration into Allograft via Inhibition of IP-10 in Rat Heart Transplant

机译:通过抑制大鼠心脏移植中的IP-10免疫抑制剂Protosappanin A减少了受体T细胞向同种异体移植的迁移。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The immunosuppressant Protosappanin A (PrA), isolated from the medicinal herb, promotes cardiac allograft survival, diminishes inflammatory cell infiltration, and inhibits interferon γ-induced protein 10 kDa (IP-10) mRNA expression in rats cardiac grafts. Binding of the chemokine IP-10 to its cognate receptor, CXCR3, plays crucial roles in allograft immunity, especially by mediating the recruitment of effector T cells to allografted tissues. In this study, we attempted to determine whether PrA-mediated inhibition of IP-10 contributes to the effect of reduced T cell infiltration into cardiac allograft within a rat model. Administration of PrA (25 mg/kg daily) via oral gavage following heart transplantation significantly reduced the increase of IP-10 mRNA level in allograft and prevented IP-10 secretion by peripheral blood mononuclear cells (PBMC) isolated from recipient rats seven days posttransplantation. Furthermore, in vitro experiments demonstrated that PrA addition to control PBMC prevented IP-10 secretion. Chemotactic migration assays were utilized to evaluate recipient T cell migration towards PBMC supernatant. PrA administration impaired PBMC supernatant-induced T cell migration. Additional in vitro experiments revealed that PrA slightly reduced naïve T cell migration towards chemokines. The presence of IP-10 in PBMC supernatant prevented PrA from reducing T cell migration in PrA-treated recipients. Neither CXCR3 chemokine ligand Mig nor non-CXCR3 chemokine ligand SDF-1 had any effect on T cell migration in PrA-treated recipients. The addition of anti-CXCR3 antibody restored PrA-mediated inhibition of T cell migration. Immunofluorescence microscopy showed that IP-10 was expressed mainly in CD68 positive infiltrating monocytes. Furthermore, PrA consistently reduced CXCR3+T cell infiltration into cardiac allografts. The reduced intensity of CXCR3 staining in PrA-treated allografts contributed to the previously depressed naïve T cell migrating activity induced by PrA. Collectively, these data indicate that PrA inhibition of IP-10 activity reduced recipient T cell migration and infiltration of cardiac allografts, thus partially explaining the immunosuppressive effect of PrA.
机译:从药草中分离得到的免疫抑制剂Protosappanin A(PrA)可以促进心脏同种异体移植物的存活,减少炎症细胞的浸润,并抑制干扰素γ诱导的大鼠心脏移植物中γ诱导的蛋白10 kDa(IP-10)mRNA的表达。趋化因子IP-10与其同源受体CXCR3的结合在同种异体移植免疫中起着至关重要的作用,特别是通过介导效应T细胞募集到同种异体组织中。在这项研究中,我们试图确定PrA介导的IP-10抑制是否有助于减少T细胞浸入大鼠同种异体心脏模型的效果。心脏移植后通过管饲法给予PrA(每天25 mg / kg)可显着降低同种异体移植中IP-10 mRNA水平的增加,并防止移植后7天从受体大鼠分离的外周血单核细胞(PBMC)分泌IP-10分泌。此外,体外实验表明,向对照PBMC中添加PrA可以防止IP-10分泌。利用趋化迁移测定法来评估受体T细胞向PBMC上清液的迁移。 PrA给药损害PBMC上清液诱导的T细胞迁移。额外的体外实验表明,PrA可以稍微减少纯正T细胞向趋化因子的迁移。 PBMC上清液中IP-10的存在阻止了PrA减少PrA处理的受体中T细胞的迁移。 CXCR3趋化因子配体Mig和非CXCR3趋化因子配体SDF-1都不对PrA治疗的受体中的T细胞迁移产生任何影响。抗CXCR3抗体的添加恢复了PrA介导的T细胞迁移抑制。免疫荧光显微镜检查显示IP-10主要在CD68阳性浸润性单核细胞中表达。此外,PrA持续减少CXCR3 + T细胞向心脏同种异体移植物中的浸润。 PrA处理的同种异体移植物中CXCR3染色强度的降低导致了先前由PrA诱导的幼稚T细胞迁移活性降低。总的来说,这些数据表明PrA对IP-10活性的抑制减少了受体T细胞迁移和心脏同种异体移植物的浸润,因此部分解释了PrA的免疫抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号